We are live on ! Find out more
Comerica Bank

Comerica Bank Portfolio holdings

AUM $25.1B
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
+11.79%
1 Year Est. Return
+24.68%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.7B
AUM Growth
+$2.51B
Cap. Flow
+$433M
Cap. Flow %
1.99%
Top 10 Hldgs %
18.62%
Holding
3,897
New
108
Increased
1,481
Reduced
1,602
Closed
170

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.71%
2 Technology 18.77%
3 Healthcare 11.57%
4 Financials 9.41%
5 Industrials 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLVM icon
1626
Sylvamo
SLVM
$1.47B
$810K ﹤0.01%
16,497
-104
-0.6% -$4.86K
TNC icon
1627
Tennant Co
TNC
$1.16B
$809K ﹤0.01%
8,724
+62
+0.7% +$5.14K
MXL icon
1628
MaxLinear
MXL
$6.84B
$807K ﹤0.01%
33,949
+193
+0.6% +$3.78K
REAL icon
1629
The RealReal
REAL
$1.19B
$804K ﹤0.01%
400,000
PCRX icon
1630
Pacira BioSciences
PCRX
$999M
$803K ﹤0.01%
23,806
+723
+3% +$21.2K
USRT icon
1631
iShares Core US REIT ETF
USRT
$4.37B
$800K ﹤0.01%
14,743
+917
+7% +$44.8K
NMRK icon
1632
Newmark Group
NMRK
$2.56B
$800K ﹤0.01%
72,961
-15,646
-18% -$118K
SUPN icon
1633
Supernus Pharmaceuticals
SUPN
$2.51B
$799K ﹤0.01%
27,620
-4
-0% -$106
TRMK icon
1634
Trustmark
TRMK
$2.73B
$799K ﹤0.01%
28,653
-472
-2% -$10.9K
KAI icon
1635
Kadant
KAI
$3.16B
$796K ﹤0.01%
2,839
+2,615
+1,167% +$654K
TFIN icon
1636
Triumph Financial Inc
TFIN
$1.51B
$794K ﹤0.01%
9,900
-319
-3% -$21.6K
FXL icon
1637
First Trust Technology AlphaDEX Fund
FXL
$2.77B
$792K ﹤0.01%
6,183
+183
+3% +$21.3K
AMWD
1638
DELISTED
American Woodmark
AMWD
$791K ﹤0.01%
8,517
+77
+0.9% +$6K
PWV icon
1639
Invesco Large Cap Value ETF
PWV
$1.86B
$790K ﹤0.01%
15,562
+1,506
+11% +$71.5K
VUSB icon
1640
Vanguard Ultra-Short Bond ETF
VUSB
$10.2B
$789K ﹤0.01%
15,964
+8,863
+125% +$436K
GSBD icon
1641
Goldman Sachs BDC
GSBD
$1.13B
$789K ﹤0.01%
53,824
+6,194
+13% +$89.8K
DBEU icon
1642
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$777M
$788K ﹤0.01%
20,859
+426
+2% +$15.3K
CPRX
1643
DELISTED
Catalyst Pharmaceutical
CPRX
$786K ﹤0.01%
46,780
+1,014
+2% +$13.9K
JSMD icon
1644
Janus Henderson Small/Mid Cap Growth Alpha ETF
JSMD
$1.05B
$785K ﹤0.01%
11,934
+1,054
+10% +$62.6K
ASTH icon
1645
Astrana Health
ASTH
$1.8B
$784K ﹤0.01%
20,476
+611
+3% +$20.3K
OPLN
1646
Openlane
OPLN
$4.21B
$782K ﹤0.01%
52,806
-545
-1% -$7.92K
BOE icon
1647
BlackRock Enhanced Global Dividend Trust
BOE
$682M
$782K ﹤0.01%
78,834
+237
+0.3% +$2.28K
SABR icon
1648
Sabre
SABR
$977M
$781K ﹤0.01%
177,457
+19,607
+12% +$75.7K
EPAC icon
1649
Enerpac Tool Group
EPAC
$1.82B
$781K ﹤0.01%
25,107
-800
-3% -$22.8K
FBT icon
1650
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.94B
$780K ﹤0.01%
4,935
-842
-15% -$121K

Similar funds

Comerica Bank's Q4 2023 Portfolio in Review

As of Q4 2023, Comerica Bank held 3,897 positions worth $21.7B, up 13% from $19.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Comerica Bank's Q4 2023 filing shows 108 new, 1,481 increased, 1,602 reduced and 170 closed positions. Its largest new stake was Distillate US Fundamental Stability & Value ETF: 168,448 shares worth $8.32M. The largest sale was Vanguard Total Corporate Bond ETF, an estimated $14.4M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

  • Comerica Bank's largest Q4 2023 buy was Distillate US Fundamental Stability & Value ETF: 168,448 shares worth $8.32M.
  • Comerica Bank added most to Eli Lilly in Q4 2023, an estimated $142M increase.
  • Comerica Bank's biggest Q4 2023 reduction was Vanguard Total Corporate Bond ETF, cutting an estimated $14.4M.
  • Comerica Bank fully exited Activision Blizzard in Q4 2023, selling an estimated $10.3M.
  • Comerica Bank's ten largest holdings make up 19% of its $21.7B portfolio in Q4 2023.
  • Comerica Bank opened 108 new positions and closed 170 in Q4 2023.
  • Comerica Bank's portfolio value rose 13% quarter-over-quarter to $21.7B.

Based on Comerica Bank's 13F filing for Q4 2023, filed 14 Feb 2024.